Insider · CIK 0001934232
Brian T. Powl
Files at KURA (Kura Oncology, Inc.). First filing Jan 28, 2025, latest Sep 29, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KURA: Kura Oncology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Kura Oncology, Inc. | $345k 32,450 shares | -19% | - | |
| 37Weak | Kura Oncology, Inc. | $54k 6,414 shares | -3% | +53% from low-30% from high | |
| 40Moderate | Kura Oncology, Inc. | $99k 8,887 shares | -6% | +102% from low-32% from high | |
| 39Weak | Kura Oncology, Inc. | $80k 8,891 shares | -8% | +62% from low-54% from high | |
| 30Weak | Kura Oncology, Inc. | $12k 1,583 shares | -3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 28, 2025 | KURA KURA ONCOLOGY, INC. | 1,583 0.00% of outstanding | $12k | Jan 28, 2025 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -9,020 | $10.50 | $95k | 160,249 | 13 d ago |
| Sep 28, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -8,000 | $10.56 | $84k | 152,249 | 13 d ago |
| Sep 29, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -15,430 | $10.75 | $166k | 136,819 | 13 d ago |
| Jan 27, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -4,842 | $8.46 | $41k | 184,847 | Jan 27, 2026 |
| Jan 27, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -1,572 | $8.46 | $13k | 183,275 | Jan 27, 2026 |
| Jan 2, 2026 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 189,689 | Jan 6, 2026 |
| Jan 2, 2026 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +100,000 | $0.00 | $0 | 100,000 | Jan 6, 2026 |
| Nov 13, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +48,900 | $0.00 | $0 | 148,576 | Nov 14, 2025 |
| Nov 14, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -8,887 | $11.18 | $99k | 139,689 | Nov 14, 2025 |
| Sep 27, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +48,900 | $0.00 | $0 | 108,567 | Sep 29, 2025 |
| Sep 29, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -8,891 | $8.94 | $80k | 99,676 | Sep 29, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -1,583 | $7.87 | $12k | 59,667 | Jan 28, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +46,250 | $0.00 | $0 | 61,250 | Jan 6, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +92,500 | $0.00 | $0 | 92,500 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.